Integrated Proteins Limited (BOM:519606)

Integrated Proteins Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	99.36	99.36	214.96	2.37	1.67	-
Revenue Growth	-53.78%	-53.78%	8954.84%	42.16%	-	-
Gross Profit Gross Profit Growth	4.34	4.34	4.71	0.15	0.2	-
Operating Income Operating Income Growth	2.78	2.78	0.91	-1.45	-1.14	-1.06
Net Income Net Income Growth	2.25	2.25	2.5	0.89	0.31	0.37
Earnings Per Share EPS Growth	0.12	0.12	0.71	0.25	0.09	0.11
EPS Growth	-83.10%	-83.10%	184.00%	177.78%	-21.01%	72.19%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Agro & Trading Agro & Trading Growth	43.76	43.76	214.96	2.37	1.67
Textile Textile Growth	46.16	46.16	-	-	-
Securities Securities Growth	9.43	9.43	-	-	-
Medical Medical Growth	0.05	0.05	-	-	-
Total Total Growth	99.41	99.41	214.96	2.37	1.67

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Short-Term Investments Cash & Short-Term Investments Growth	-0.16	-0.16	0.87	0.62	0.27	0.36
Total Debt Total Debt Growth	-	-	38.96	0.35	1.91	0.8
Net Cash (Debt) Net Cash Growth	-0.16	-0.16	-38.08	0.27	-1.64	-0.44
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.01	-0.01	-10.82	0.08	-0.51	-0.14

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	36.03	36.03	-235.65	-0.59	-1.2	-0.93
Free Cash Flow Free Cash Flow Growth	36.03	36.03	-235.65	-0.59	-1.2	-0.93
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	4.37%	4.37%	2.19%	6.36%	11.98%	-
Operating Margin	2.80%	2.80%	0.43%	-60.91%	-68.08%	-
Pretax Margin	2.85%	2.85%	1.49%	43.77%	25.03%	-
Profit Margin	2.27%	2.27%	1.16%	37.62%	18.50%	-

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 2, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	1192.26	605.07	50.87	58.15	124.10	131.66
PS Ratio	27.00	13.70	0.59	21.88	22.96	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error